KOHL MEDICAL AG, headquartered in Germany, is a prominent player in the medical technology industry, specialising in innovative solutions for surgical and diagnostic applications. Founded in 1992, the company has established a strong presence across Europe, particularly in Germany and surrounding regions, by consistently delivering high-quality medical devices and instruments. The core offerings of KOHL MEDICAL AG include advanced surgical tools and precision diagnostic equipment, designed to enhance patient outcomes and streamline medical procedures. Their commitment to quality and innovation has positioned them as a trusted partner in healthcare, with notable achievements in product development and customer satisfaction. With a focus on meeting the evolving needs of the medical community, KOHL MEDICAL AG continues to lead in the field of medical technology.
How does KOHL MEDICAL AG's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Real Estate Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
KOHL MEDICAL AG's score of 15 is lower than 87% of the industry. This can give you a sense of how well the company is doing compared to its peers.
KOHL MEDICAL AG, headquartered in Germany, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of emissions data and commitments suggests that KOHL MEDICAL AG may still be in the early stages of developing a comprehensive climate strategy. As the company does not inherit emissions data from a parent organisation, it operates independently in terms of its climate impact reporting. Without specific targets or initiatives, KOHL MEDICAL AG's approach to carbon emissions and climate commitments remains unclear. The company may benefit from establishing measurable goals and participating in recognised climate initiatives to enhance its sustainability profile in the medical sector.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
KOHL MEDICAL AG has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.